Which one of the following clinical signs is not seen in ophthalmic Graves’ disease?
What is the normal A:V ratio of retinal blood vessels?
Dalen-Fuchs nodules are pathognomic of which condition?
Significant loss of vision in a patient with hypertension can occur due to all of the following, except?
Bilateral skin depigmentation, chronic uveitis, and tinnitus are features of which syndrome?
In Marfan's syndrome, which of the following ocular abnormalities is typically seen?
Amaurosis fugax may occur in all of the following conditions except?
What is the earliest pathological change observed in diabetic retinopathy?
Which of the following factors is related to diabetic retinopathy?
Which of the following investigations are indicated for anterior uveitis in a young boy?
Explanation: In Graves’ ophthalmopathy (Thyroid Eye Disease), the characteristic clinical presentation is defined by **decreased** rather than increased frequency of blinking. ### Why "Frequent Blinking" is the Correct Answer In Graves’ disease, patients exhibit **Stellwag’s sign**, which is characterized by **infrequent or incomplete blinking**. This occurs due to the overactivity of the sympathetic nervous system and the contraction of the levator palpebrae superioris and Müller’s muscles. Frequent blinking is not a feature of this condition; instead, the reduced blink rate contributes to corneal exposure and dryness. ### Explanation of Other Options * **A. Lid Retraction (Dalrymple’s Sign):** This is the most common clinical sign of Graves’ ophthalmopathy. It refers to the widening of the palpebral fissure, making the sclera visible above the limbus in the primary position. * **C. Poor Convergence (Moebius Sign):** Due to infiltration and fibrosis of the extraocular muscles (most commonly the inferior and medial recti), patients often lose the ability to maintain convergence of the eyes on a near object. * **D. Upper Lid Lag on Down Gaze (Von Graefe’s Sign):** As the patient looks downward, the upper eyelid fails to follow the movement of the globe smoothly and remains abnormally high. ### NEET-PG High-Yield Pearls * **Mnemonic for Muscle Involvement:** **"I’M SLOW"** (Inferior rectus > Medial rectus > Superior rectus > Lateral rectus > Obliques). * **NOSPECS Classification:** Used to grade severity (0: No signs/symptoms, 1: Only signs, 2: Soft tissue involvement, 3: Proptosis, 4: Extraocular muscle involvement, 5: Corneal involvement, 6: Sight loss/Optic nerve compression). * **Joffroy’s Sign:** Absence of forehead wrinkling on upward gaze. * **Enroth’s Sign:** Edema of the eyelids.
Explanation: **Explanation:** In a healthy retina, the **Arteriole-to-Venule (A:V) ratio** is a critical clinical marker used to assess systemic vascular health. Under normal physiological conditions, retinal arterioles are slightly narrower than the corresponding venules. The standard normal ratio is **2:3** (or approximately 0.6 to 0.7). **Why 2:3 is correct:** Retinal venules are naturally more distensible and carry a larger volume of blood at lower pressure compared to arterioles, making them appear wider on ophthalmoscopy. This 2:3 ratio serves as the baseline for evaluating vascular pathology. **Analysis of Incorrect Options:** * **A. 1:2:** This indicates significant **arteriolar narrowing**. A ratio of 1:2 or less is a hallmark of pathological conditions like Hypertensive Retinopathy (Grade II/III) or retinal artery occlusion. * **C. 3:2:** This is mathematically incorrect as it suggests arterioles are wider than veins, which does not occur in normal human anatomy. * **D. 3:4:** While closer to normal than 1:2, it overestimates the width of the arteriole relative to the venule in a standard clinical setting. **High-Yield Clinical Pearls for NEET-PG:** 1. **Hypertensive Retinopathy:** The earliest sign is generalized arteriolar narrowing (A:V ratio decreases). 2. **A/V Nipping (Gunn’s Sign):** Occurs because the arteriole and venule share a common adventitial sheath; a thickened arteriole compresses the venule. 3. **Venous Tortuosity/Dilatation:** An increase in the denominator (venule width) occurs in Central Retinal Vein Occlusion (CRVO), papilledema, and hyperviscosity syndromes. 4. **Silver/Copper Wiring:** Reflects increased light reflex from the arteriolar wall due to atherosclerosis/hypertension.
Explanation: **Explanation:** **Sympathetic Ophthalmitis (SO)** is a rare, bilateral granulomatous panuveitis that occurs following a penetrating ocular injury or intraocular surgery in one eye (the "exciting eye"), subsequently affecting the fellow eye (the "sympathizing eye"). **Dalen-Fuchs nodules** are the hallmark histopathological feature of SO. They are small, discrete, yellowish-white inflammatory nodules located between the **Retinal Pigment Epithelium (RPE) and Bruch’s membrane**. They consist of clusters of epithelioid cells, macrophages, and pigment-laden cells. While they can occasionally be seen in other granulomatous conditions like Sarcoidosis or Vogt-Koyanagi-Harada (VKH) syndrome, they are traditionally considered **pathognomonic** (highly characteristic) of Sympathetic Ophthalmitis in the context of trauma. **Analysis of Incorrect Options:** * **Pathological Myopia:** Characterized by Forster-Fuchs spots (subretinal neovascularization and scarring at the macula), not Dalen-Fuchs nodules. * **Fuch’s Uveitis Syndrome:** A chronic, non-granulomatous uveitis characterized by heterochromia iridis and fine, stellate keratic precipitates; it does not feature Dalen-Fuchs nodules. * **Sarcoidosis:** While it causes granulomatous uveitis and can occasionally show similar nodules, the term "Dalen-Fuchs" is specifically linked to the RPE-Bruch's membrane complex in SO and VKH. **High-Yield Clinical Pearls for NEET-PG:** * **Histopathology of SO:** Characterized by "non-necrotizing granulomatous inflammation" with **sparing of the choriocapillaris**. * **Prevention:** Evisceration or enucleation of the injured eye within **2 weeks** of trauma significantly reduces the risk of SO. * **VKH Syndrome:** Often considered the "systemic counterpart" of SO, as it also features Dalen-Fuchs nodules but lacks a history of trauma.
Explanation: **Explanation:** The key to answering this question lies in distinguishing between **visual acuity (vision loss)** and **visual field defects/optic disc appearance** in the context of hypertensive crisis. **Why Papilledema is the correct answer:** In malignant hypertension (Grade IV Hypertensive Retinopathy), bilateral disc edema occurs due to increased intracranial pressure or localized ischemia. Importantly, in the early stages of papilledema, **central visual acuity is typically preserved**. Patients may experience transient visual obscurations (seconds of blurring) or an enlarged blind spot, but "significant loss of vision" is not a primary feature unless secondary complications like macular edema or optic atrophy develop over time. **Analysis of Incorrect Options:** * **Occipital Infarct:** Hypertension is a major risk factor for stroke. An infarct in the occipital cortex (visual cortex) leads to sudden, significant vision loss, typically presenting as contralateral homonymous hemianopia or cortical blindness. * **Anterior Ischemic Optic Neuropathy (AION):** Hypertension causes arteriosclerotic changes in the short posterior ciliary arteries. Non-arteritic AION presents with sudden, painless, significant monocular vision loss and an altitudinal field defect. * **Retinal Hemorrhage:** While small flame-shaped hemorrhages may not affect vision, a large **vitreous hemorrhage** or a hemorrhage involving the **fovea/macula** (common in hypertensive retinopathy or associated retinal vein occlusions) will cause a profound drop in visual acuity. **Clinical Pearls for NEET-PG:** * **Modified Scheie Classification:** Grade IV is defined by the presence of Papilledema. * **Elschnig Spots:** These are small, black spots surrounded by yellow halos, representing choroidal infarcts in severe hypertension. * **Siegrist Streaks:** Linear hyperpigmented streaks along choroidal vessels, indicating fibrinoid necrosis. * **Management:** In hypertensive emergency with papilledema, blood pressure should be lowered gradually (25% in the first 2 hours) to prevent watershed infarcts in the optic nerve and brain.
Explanation: **Explanation:** **Vogt-Koyanagi-Harada (VKH) Syndrome** is a multisystem autoimmune disorder directed against melanocyte-containing tissues, primarily affecting the eyes, ears, skin, and meninges. It typically presents in four stages: 1. **Prodromal:** Meningismus and tinnitus. 2. **Uveitic:** Bilateral granulomatous panuveitis with exudative retinal detachments. 3. **Chronic (Convalescent):** Depigmentation of the choroid (**"Sunset glow fundus"**) and skin (vitiligo, poliosis, and alopecia). 4. **Chronic Recurrent:** Smoldering anterior uveitis. The triad of bilateral uveitis, auditory symptoms (tinnitus/hearing loss), and integumentary changes (vitiligo) is pathognomonic for VKH. **Why the other options are incorrect:** * **Waardenburg Syndrome:** A genetic disorder characterized by sensorineural deafness and pigmentary anomalies (white forelock, heterochromia iridis), but it **does not** cause uveitis. * **Alport Syndrome:** A basement membrane disorder (Type IV Collagen mutation) presenting with sensorineural deafness and renal failure. Ocular signs include **anterior lenticonus** and dot-and-fleck retinopathy, not uveitis or vitiligo. * **Werner Syndrome:** A progeroid (premature aging) syndrome. Key features include bilateral cataracts, scleroderma-like skin changes, and short stature, but not chronic uveitis. **High-Yield Clinical Pearls for NEET-PG:** * **Sunset Glow Fundus:** A classic sign of the chronic stage of VKH due to depigmentation. * **Sugiura’s Sign:** Perilimbal vitiligo (depigmentation of the limbus), seen in the convalescent stage. * **Dalen-Fuchs Nodules:** Small, yellow-white granulomatous lesions between the RPE and Bruch’s membrane (also seen in Sympathetic Ophthalmitis). * **Treatment:** High-dose systemic corticosteroids are the mainstay of therapy.
Explanation: **Explanation:** **1. Why Option B is Correct:** In Marfan’s syndrome, the most characteristic ocular finding is **Ectopia Lentis** (subluxation of the lens), occurring in approximately 50-80% of patients. The subluxation is typically **Supero-temporal** (upward and outward). This occurs due to a mutation in the **FBN1 gene** on chromosome 15, which leads to a deficiency in **Fibrillin-1**. This protein is a major component of the ciliary zonules; their weakness or breakage causes the lens to displace, usually away from the area of maximum zonular loss. **2. Why Other Options are Incorrect:** * **Option A (Infero-nasal):** This is the classic direction of lens subluxation in **Homocystinuria**. A high-yield differentiator is that in Homocystinuria, zonules are completely disintegrated, whereas in Marfan’s, they are usually intact but stretched. * **Option C (Corneal edema):** While Marfan’s is associated with a flat cornea (*Cornea Plana*), acute corneal edema is not a typical feature unless there is a secondary complication like total lens dislocation into the anterior chamber. * **Option D (Increased IOP):** While glaucoma can occur as a secondary complication (due to pupillary block or lens dislocation), it is not the "typical" primary ocular abnormality used to identify the syndrome in exams. **3. High-Yield Clinical Pearls for NEET-PG:** * **Direction Mnemonic:** **M**arfan = **M**ore (Up/Superior); **H**omocystinuria = **H**ypo (Down/Inferior). * **Other Ocular Features:** High myopia (most common refractive error), flat cornea, increased axial length, and increased risk of Rhegmatogenous Retinal Detachment. * **Systemic Association:** Always look for arachnodactyly, tall stature, and aortic root dilation/dissection in the clinical stem. * **Microspherophakia:** Often associated with Weill-Marchesani syndrome (where subluxation is usually inferior).
Explanation: **Explanation:** **Amaurosis Fugax** refers to a sudden, transient, painless loss of vision (usually unilateral) that typically lasts for seconds to minutes, followed by complete recovery. It is essentially a "TIA of the retina" caused by temporary vascular compromise. **Why Papillitis is the Correct Answer:** Papillitis (Inflammatory Optic Neuritis) is characterized by **persistent** vision loss that develops over hours to days and is often associated with pain on eye movement. It is an inflammatory condition, not a transient vascular event. Therefore, it does not cause the fleeting, episodic vision loss characteristic of amaurosis fugax. **Analysis of Incorrect Options:** * **Papilloedema:** Transient visual obscurations (TVOs) lasting 1–30 seconds are a hallmark of papilloedema. They occur due to transient fluctuations in perfusion pressure at the optic nerve head caused by increased intracranial pressure. * **Giant Cell Arteritis (GCA):** This is a critical cause of amaurosis fugax. It involves inflammation of the ophthalmic or ciliary arteries, leading to intermittent ischemia before permanent occlusion (AION) occurs. * **Raynaud’s Disease:** Though rare, vasospasm of the retinal or ciliary arteries (similar to the digital vasospasm seen in Raynaud's) can lead to transient episodes of vision loss. **High-Yield Clinical Pearls for NEET-PG:** * **Most Common Cause:** The most frequent cause of amaurosis fugax is an **embolic phenomenon** from an ipsilateral carotid artery plaque. * **Hollenhorst Plaque:** A bright, refractile cholesterol crystal seen at retinal vessel bifurcations, highly suggestive of carotid artery disease. * **Duration:** TVOs in papilloedema last seconds; Amaurosis fugax from carotid disease lasts 2–10 minutes; Migraine auras last 15–30 minutes. * **Management:** Always perform a Carotid Doppler and ESR/CRP in elderly patients presenting with amaurosis fugax to rule out stroke risk and GCA.
Explanation: ### Explanation **Correct Answer: D. Microaneurysm** **Why it is correct:** The hallmark of diabetic retinopathy (DR) is microvascular damage. The **earliest clinical sign** visible on ophthalmoscopy is the **microaneurysm**. Pathologically, the process begins with the **loss of intramural pericytes** (cells that provide structural support to capillary walls). This leads to focal weakening and outpouching of the capillary wall. On fundoscopy, these appear as tiny, round, red dots, typically located in the inner nuclear layer of the retina. On Fluorescein Angiography (FFA), they appear as "hyperfluorescent dots," often more numerous than those seen clinically. **Why the other options are incorrect:** * **A. Hard Exudates:** These are yellowish-waxy deposits of lipoproteins and lipid-laden macrophages in the outer plexiform layer. They occur due to chronic vascular leakage *after* microaneurysms have already formed. * **B. Soft Exudates (Cotton Wool Spots):** These represent areas of retinal ischemia (nerve fiber layer infarction). They appear later in the disease process as pre-proliferative changes. * **C. Dot Hemorrhage:** These occur when microaneurysms rupture or deep capillaries leak into the middle layers of the retina. While common in NPDR, they typically follow the formation of microaneurysms. **High-Yield Clinical Pearls for NEET-PG:** * **Earliest Pathological Change:** Loss of pericytes (Pericyte:Endothelial cell ratio drops from 1:1 to 1:0). * **Earliest Clinical Sign:** Microaneurysm. * **Earliest Change on FFA:** Microaneurysms (appearing as pin-point leaks). * **First Functional Change:** Alteration in Contrast Sensitivity and Color Vision (Blue-Yellow). * **Most Common Cause of Vision Loss in DR:** Diabetic Macular Edema (DME).
Explanation: **Explanation:** The development and progression of Diabetic Retinopathy (DR) are influenced by several factors, but the **duration of the disease** is the most significant and consistent predictor. **1. Why "Duration of disease" is correct:** The longer a patient has diabetes, the higher the cumulative risk of microvascular damage. After 20 years of diabetes, nearly 99% of Type 1 patients and 60% of Type 2 patients will show some signs of retinopathy. It is a time-dependent metabolic insult to the retinal capillaries, leading to basement membrane thickening and pericyte loss. **2. Analysis of incorrect options:** * **Severity of disease (B):** This is a vague clinical term. Retinopathy can occur in "mild" cases if the duration is long enough. The severity of hyperglycemia (HbA1c) matters, but duration remains the primary risk factor. * **Family history (C):** While genetics may play a minor role in susceptibility, DR is primarily a metabolic complication rather than a purely hereditary one. * **Control of diabetes (D):** While strict glycemic control (as proven by the DCCT and UKPDS trials) significantly *slows the progression* and delays the onset, it cannot entirely prevent DR if the duration of the disease is sufficiently long. **High-Yield Clinical Pearls for NEET-PG:** * **Most important risk factor:** Duration of diabetes. * **Most important modifiable risk factor:** Glycemic control (HbA1c levels). * **Other risk factors:** Pregnancy (can cause rapid worsening), Hypertension, Nephropathy, and Anemia. * **First clinical sign:** Microaneurysms (found in the Inner Nuclear Layer). * **First pathological sign:** Loss of pericytes and basement membrane thickening. * **Screening:** Type 1 DM (5 years after diagnosis); Type 2 DM (at the time of diagnosis).
Explanation: **Explanation:** In a young boy presenting with anterior uveitis, the primary clinical suspicion shifts toward congenital or early-acquired infections. The **TORCH group** (Toxoplasmosis, Other [Syphilis], Rubella, Cytomegalovirus, and Herpes Simplex) represents the most common infectious causes of uveitis in the pediatric population. Among these, **Toxoplasmosis** is the most frequent cause of posterior uveitis that often presents with a secondary anterior chamber reaction (breakdown of the blood-aqueous barrier). **Analysis of Options:** * **TORCH agents (Correct):** Screening for these infections is the standard initial step in pediatric uveitis, as identifying an infectious etiology is crucial for starting specific antimicrobial therapy and preventing permanent visual loss. * **HLA B27 & X-ray Sacroiliac Joint (Incorrect):** While HLA-B27 associated spondyloarthropathies (like Ankylosing Spondylitis) are common causes of acute anterior uveitis in adults and older adolescents, they are less common in very young children. These investigations are typically reserved for patients showing systemic symptoms like lower back pain or joint stiffness. * **ELISA for HIV (Incorrect):** While HIV can cause various ocular manifestations, it is not a routine first-line investigation for isolated anterior uveitis in a child unless there are specific risk factors or signs of opportunistic infections (like CMV retinitis). **Clinical Pearls for NEET-PG:** * **Most common cause of pediatric uveitis:** Juvenile Idiopathic Arthritis (JIA). Note that JIA-associated uveitis is typically **chronic, bilateral, and asymptomatic (white eye)**, requiring frequent screening. * **Toxoplasmosis:** Characteristically presents as a "headlight in the fog" appearance (active retinochoroiditis with overlying vitritis). * **Band-shaped keratopathy:** A classic complication of chronic uveitis in children, especially in JIA.
Diabetes Mellitus
Practice Questions
Hypertension
Practice Questions
Autoimmune Disorders
Practice Questions
Thyroid Disease
Practice Questions
HIV and AIDS
Practice Questions
Hematological Disorders
Practice Questions
Neurological Disorders
Practice Questions
Dermatological Conditions
Practice Questions
Pregnancy-Related Eye Changes
Practice Questions
Metabolic Disorders
Practice Questions
Ocular Toxicity of Systemic Medications
Practice Questions
Infectious Systemic Diseases
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free